ProQR Therapeutics has dosed the first patient in a phase 1/2 trial of QR-1123, its treatment candidate for autosomal dominant retinitis pigmentosa, according to a press release.The first-in-human AURORA trial, consisting of single-dose and multiple-do…
Nicotine reduces macular microcirculation
A decrease in macular microcirculation was detected after nicotine use, according to a study.Eighteen young, healthy, nonsmoking subjects and 18 gender-matched controls were enrolled in the randomized, placebo-controlled study. Those in the study group…
Johnson & Johnson Vision names new worldwide surgical vision president
Warren Foust has been named as worldwide president of Surgical Vision at Johnson & Johnson Vision, taking over from Tom Frinzi, who will retire at the end of the year, the company announced in a press release.Foust joined Johnson & Johnson in 2011 thro…
Study shows how diet plays a role in age-related macular degeneration
Participants who ate a diet high in red and processed meat, fried food, refined grains and high-fat dairy were three times more likely to develop an eye condition that damages the retina and affects a person’s central vision, according to the results o…
Beta Bionics iLet Bionic Pancreas System Gets FDA Breakthrough Designation
Beta Bionics, a firm based in Boston, MA, won Breakthrough Device designation from the FDA for its iLet Bionic Pancreas System, a wearable designed to automatically control blood-sugar levels. Unlike traditional insulin pumps, the iLet doesn’t need any input from the patient about their dietary intake, insulin delivery rates, nor are bolus do (Read more...)
Notal Vision completes $25 million in funding
Ganot Capital has extended a funding round to Notal Vision to $25 million to support the growth of the company’s ForeseeHome AMD monitoring program, according to a press release.“Pursuing additional funding has allowed us to expand our ForeseeHome fiel…